Generation of in vitro intraocular tumor models for pre-clinical drug screening using nanotechnology
Justin B Lendermon(University of Tennessee Health Science Center), Vanessa Marie Morales(University of Tennessee Health Science Center), Jena J. Steinle(Wayne State University), Matthew W. Wilson(Philadelphia VA Medical Center), Nabil Saleh(Ain Shams University), Ryan P. Lee(Johns Hopkins University), Anderson Hudgens Webb(University of Tennessee Health Science Center), Bradley T Gao(University of Tennessee Health Science Center)
Investigative Ophthalmology & Visual Science
June 11, 2015
Cited by 0
Related Papers
Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma
|BMC Cancer|2017|279
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21
|Science Translational Medicine|2019|135
Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors
|Cell Reports|2021|107
Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors
|Cell|2023|105
Synthesis and antibacterial activity of some new fused chromenes
|ARKIVOC|2007|91